Restrictive Disorders Flashcards
(116 cards)
What is Idiopathic Pulmonary Fibrosis?
It is a type of interstitial lung disease for which the cause is unknown. It is a progressive, chronic, and fatal condition characterized by excessive fibrotic tissue in the interstitial tissues of the lungs.
What are some other names for Idiopathic Pulmonary Fibrosis?
Usual Interstitial Pneumonia, cryptogenic fibrosing alveolitis, interstitial fibrosis.
What are some factors that may increase the risk of developing idiopathic pulmonary fibrosis?
Genetics, environmental exposures to dusts and tobacco, iatrogenic causes- medication or radiation, comorbidities such as GERD, obesity, emphysema.
What role does inflammation play in idiopathic pulmonary fibrosis?
It doesn’t. It may be present but it is not the primary driving factor.
What is the primary driving factor of idiopathic pulmonary fibrosis?
Aberrant response of the epithelial cells to micro-injuries. Fibro-genetic cytokines are released in response to injury which results in fibroblast proliferation. Also decreased responsiveness to apoptosis so normal pruning of tissue is limited and scar tissue develops uninhibited.
What is TGF-B?
Transforming growth factor B1 is a secrete protein that performs many cellular functions, including control of cell growth, proliferation, differentiation, and apoptosis. It enhances the remodeling of lung interstitium in idiopathic pulmonary fibrosis.
What happens to Type I and Type II pneumocytes in idiopathic pulmonary fibrosis?
The integrity of the basement membrane as well as the Type I pneumocytes is lost, and rapid growth of Type II pneumocytes occurs to re-establish the barrier as there is a signal failure to stop proliferation.
Describe the disease process of idiopathic pulmonary fibrosis.
- Some initial injury damages alveolar surface and basement membrane, we have formation of a wound clot and initiation of platelets and fibrin
- We re-establish the extracellular matrix, new vessels form, alveolar type II cells re-establish barrier
- There is a lack of pruning of the new extracellular matrix and lack of conversion of AECII cells to AECI cells
- The tension provided by the extracellular matrix on the airways is what produces the honeycomb pattern on HRCT which eventually causes traction bronchiectasis
What are the signs and symptoms of idiopathic pulmonary fibrosis?
Dry and non-productive cough, new onset exertional dyspnea, finger clubbing, fine late inspiratory crackles
What is an important thing to ask about in the patient’s history when you suspect idiopathic pulmonary fibrosis?
A detailed occupational history and any potential exposures to causative agents (organic/inorganic dust, tobacco smoke, etc.)
What might you expect to see on inspection and on an ABG of someone with idiopathic pulmonary fibrosis?
High RR and shallow Vt; Unless the patient is very end-stage they often have respiratory alkalosis
What receptors are stimulated and cause shallow breathing in idiopathic pulmonary fibrosis patients?
Pulmonary irritant receptors (increased traction due to restriction) and Juxtacapillary receptors (fibrotic changes to A/C membrane or interstitium.
Is the rapid shallow breathing in idiopathic pulmonary fibrosis due to chemical or non-chemical factors?
Non-chemical
What disease may pulmonary fibrosis lead to if left untreated?
Pulmonary hypertension; could see JVD and peripheral edema
What findings may you observe on CXR of someone who has pulmonary fibrosis?
Bilateral lower lobe opacities and possible decrease in lung volumes
What lab findings may be found in a patient with pulmonary fibrosis?
Results of blood tests are generally normal and there is no associated systemic disease because it is isolated to the lungs.
How do we diagnose idiopathic pulmonary fibrosis?
It requires exclusion of known causes like environmental exposure, medications, and systemic diseases
What diagnostic tools would we use to diagnose idiopathic pulmonary fibrosis?
CT, lung biopsy, PFT indicating restrictive disease, BAL to rule out other inflammatory causes.
What are the goals of therapy for a patient with idiopathic pulmonary fibrosis?
To slow progression, improve function, comfort, and avoid complications (we cannot cure or reverse the disease)
What is Pirfenidone?
Used to treat IPF. Anti-inflammatory, antioxidant, antifibrotic; used to slow progression
What is Nintedanib?
Use to treat IPF. Inhibits fibroblast, vascular, and platelet derived growth factors and slows decline in lung function.
What drug may be used to treat IPF but is still under investigation?
Thalidomide. It is anti-inflammatory, anti-angiogenic, and immunomodulatory; suppressed fibrotic response in animal models.
When IPF has progressed enough to cause pulmonary HTN, what is a treatment we may use?
Sildenafil: a phosphodiesterase 5 inhibitor that dilates well ventilated vessels.
What are some alternative therapies for pulmonary fibrosis?
Lung transplantation, pulmonary rehab, prevention of exacerbation